Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Kidney International Reports
|
June 4, 2026
Functional Characterization of a Novel Intronic Complement Factor I Variant in Factor I Deficiency and Atypical Hemolytic Uremic Syndrome
Simon Péter Nagy, Sarolta Dobner, Fanni Szumutku, et al.
Journal of the American Society of Nephrology : JASN
|
December 29, 2017
Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome
Martina Gaggl, Christof Aigner, Dorottya Csuka, et al.
Kidney Medicine
|
August 1, 2020
Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic Microangiopathy
Natalja Haninger-Vacariu, Christof Aigner, Renate Kain, et al.
Journal of Extracellular Biology
|
June 28, 2024
Small extracellular vesicles are released ex vivo from platelets into serum and from residual blood cells into stored plasma
Małgorzata S Małys, Maximilian C Köller, Kristin Papp, et al.
Journal of Clinical Medicine
|
April 5, 2020
Sex Differences in Clinical Presentation and Outcomes among Patients with Complement-Gene-Variant-Mediated Thrombotic Microangiopathy
Christof Aigner, Martina Gaggl, Renate Kain, et al.
Kidney Medicine
|
July 26, 2023
Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes
Natalja Haninger-Vacariu, Andreas Gleiss, Martina Gaggl, et al.
Frontiers in Medicine
|
August 8, 2022
Three-Month Follow-Up of Heterologous vs. Homologous Third SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Secondary Analysis of a Randomized Controlled Trial
Andreas Heinzel, Eva Schrezenmeier, Florina Regele, et al.
Frontiers in Medicine
|
October 27, 2022
Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial
Andreas Heinzel, Eva Schrezenmeier, Florina Regele, et al.
Journal of Nephrology
|
February 18, 2021
Eculizumab use in a tertiary care nephrology center: data from the Vienna TMA cohort
Christof Aigner, Martina Gaggl, Gunar Stemer, et al.
European Journal of Internal Medicine
|
December 4, 2019
Preemptive plasma therapy prevents atypical hemolytic uremic syndrome relapse in kidney transplant recipients
Christof Aigner, Georg A Böhmig, Farsad Eskandary, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Kidney International Reports
|
June 4, 2026
Functional Characterization of a Novel Intronic Complement Factor I Variant in Factor I Deficiency and Atypical Hemolytic Uremic Syndrome
Simon Péter Nagy, Sarolta Dobner, Fanni Szumutku, et al.
Journal of the American Society of Nephrology : JASN
|
December 29, 2017
Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome
Martina Gaggl, Christof Aigner, Dorottya Csuka, et al.
Kidney Medicine
|
August 1, 2020
Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic Microangiopathy
Natalja Haninger-Vacariu, Christof Aigner, Renate Kain, et al.
Journal of Extracellular Biology
|
June 28, 2024
Small extracellular vesicles are released ex vivo from platelets into serum and from residual blood cells into stored plasma
Małgorzata S Małys, Maximilian C Köller, Kristin Papp, et al.
Journal of Clinical Medicine
|
April 5, 2020
Sex Differences in Clinical Presentation and Outcomes among Patients with Complement-Gene-Variant-Mediated Thrombotic Microangiopathy
Christof Aigner, Martina Gaggl, Renate Kain, et al.
Kidney Medicine
|
July 26, 2023
Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes
Natalja Haninger-Vacariu, Andreas Gleiss, Martina Gaggl, et al.
Frontiers in Medicine
|
August 8, 2022
Three-Month Follow-Up of Heterologous vs. Homologous Third SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Secondary Analysis of a Randomized Controlled Trial
Andreas Heinzel, Eva Schrezenmeier, Florina Regele, et al.
Frontiers in Medicine
|
October 27, 2022
Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial
Andreas Heinzel, Eva Schrezenmeier, Florina Regele, et al.
Journal of Nephrology
|
February 18, 2021
Eculizumab use in a tertiary care nephrology center: data from the Vienna TMA cohort
Christof Aigner, Martina Gaggl, Gunar Stemer, et al.
European Journal of Internal Medicine
|
December 4, 2019
Preemptive plasma therapy prevents atypical hemolytic uremic syndrome relapse in kidney transplant recipients
Christof Aigner, Georg A Böhmig, Farsad Eskandary, et al.
Page
of 4